Fuentes J A, Ruiz-Gayo M, Manzanares J, Vela G, Reche I, Corchero J
Departamento de Farmacología, Facultad de Farmacia, Universidad Complutense, Madrid, Spain.
Life Sci. 1999;65(6-7):675-85. doi: 10.1016/s0024-3205(99)00290-8.
Among other pharmacological properties analgesia is one of the important features of cannabinoids with therapeutical prospects. Cannabinoids have been shown to produce antinociception in experimental animals and humans. Recently a new system of neuromodulation based upon the existence of cannabinoid receptors and their endogenous agonists has emerged. This has been proposed as another of the endogenous pain control systems. Current evidence indicate an interaction between cannabinoid and opioid systems, the latter being of known relevance in nociception. The fact that either exogenous or endogenous opioids enhanced cannabinoid-induced antinociception suggests simultaneous activation of both opioid and cannabinoid receptors by drugs as a new analgesic strategy.
在其他药理特性中,镇痛是大麻素具有治疗前景的重要特性之一。大麻素已被证明在实验动物和人类中能产生抗伤害感受作用。最近,基于大麻素受体及其内源性激动剂的存在,出现了一种新的神经调节系统。这已被提议作为另一种内源性疼痛控制系统。目前的证据表明大麻素系统与阿片系统之间存在相互作用,后者在痛觉感受中具有已知的相关性。外源性或内源性阿片类药物均可增强大麻素诱导的抗伤害感受作用,这一事实表明,药物同时激活阿片受体和大麻素受体是一种新的镇痛策略。